April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Clinically Integrated
Networks and the Role
for Radiation On...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Why Clinical Integration?
• Today’s volume-based, fee-for-se...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Fundamentals Driving
Clinical Integration
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Adapting to your
“Customers” Demands
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Defining Clinical Integration
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Key Characteristics of a CIN
• Well-defined governance struc...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Investing in Clinical Integration
as a Strategy
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Demonstrating the Business
Case for Clinical Integration
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Understanding Basic
CIN Economics
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Recognizing the Unique Challenge
of Engaging Physicians
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Developing a CIN
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Launching a CIN
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Operating the CIN
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Recent Trends in Cancer Care
Clinical Integration Strategy
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Recent Trends in Cancer Care Clinical
Integration Strategy
1...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Patient-Centered Medical Homes
• CMS awarded a $19
million g...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Patient-Centered Medical Homes
• Gaps between quality and ca...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Commonality Among Top
Oncology Programs
Oncology
leaders at
...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Emerging Personalized,
Molecular Treatments
 Ability to tar...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Genome-Based Cancer Care
“Arms Race”
• Cancer care providers...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Genome Driving Future of
Cancer Treatment
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Clinical Integration and
Radiation Oncology
General Consider...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Consider: Transition to Coordinated
Care
• Consolidation of ...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Consider: Transition to Coordinated
Care
• Many health syste...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Consider: Narrow Network Concerns
for Cancer Centers
Cancer ...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Consider: Narrow Network Concerns
for Cancer Centers
• The A...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
The National Benchmark for
Oncology, 2013 Report on 2012
Data
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Survey Responses
Response to survey question “Do you expect ...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Survey Responses
Response to survey question “If yes, do you...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Survey Responses
Response to survey question “Do the physici...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Survey Responses
Source of clinical pathways
• Practices, 46...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Survey Responses
Response to survey question “How do you use...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Why Clinical Integration?
• Today’s volume-based, fee-for-se...
April 24-25, 2014
Prepared for SATRO ® 16th Annual Conference
Christopher Wilson, J.D., M.P.H.
Senior Manager
cwilson@pyap...
Upcoming SlideShare
Loading in …5
×

PYA Thought Leader Defines Role of Radiation Oncology in Clinical Integration

874 views

Published on

PYA Senior Consulting Manager Chris Wilson presented “Clinically Integrated Networks (CIN) and the Role for Radiation Oncology” at the SATRO® 16 Conference, April 24-25, 2014, at the Crowne Plaza Ravinia in Atlanta, Georgia.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
874
On SlideShare
0
From Embeds
0
Number of Embeds
315
Actions
Shares
0
Downloads
13
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

PYA Thought Leader Defines Role of Radiation Oncology in Clinical Integration

  1. 1. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Clinically Integrated Networks and the Role for Radiation Oncology A Presentation For: SATRO® 16th Annual Conference April 24-25, 2014
  2. 2. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Why Clinical Integration? • Today’s volume-based, fee-for-service system is based on independence: each provider is paid for providing a discrete service, without regard to others’ performance. • Tomorrow’s value-based payment systems, however, will demand interdependence: providers will be rewarded for quality and efficiency achieved through collaborative care.
  3. 3. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Fundamentals Driving Clinical Integration
  4. 4. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Adapting to your “Customers” Demands
  5. 5. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Defining Clinical Integration
  6. 6. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Key Characteristics of a CIN • Well-defined governance structure to promote organizational goals while protecting individual interests • Physician-driven, professional management • Data-driven • Relentless focus on improving the health of the population served • Adherence to evidence-based medicine guidelines and clinical protocols
  7. 7. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Investing in Clinical Integration as a Strategy
  8. 8. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Demonstrating the Business Case for Clinical Integration
  9. 9. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Understanding Basic CIN Economics
  10. 10. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Recognizing the Unique Challenge of Engaging Physicians
  11. 11. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Developing a CIN
  12. 12. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Launching a CIN
  13. 13. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Operating the CIN
  14. 14. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Recent Trends in Cancer Care Clinical Integration Strategy
  15. 15. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Recent Trends in Cancer Care Clinical Integration Strategy 1. Patient-Centered Medical Home (PCMH) model is becoming increasingly common for oncology to combat the high costs of oncology services. 2. Commonalities Among Top Oncology Programs, such as increasing focus on patient-centered care and cost-awareness. 3. Emerging Personalized, Molecular Treatments’ ability to specifically target molecular abnormalities driving tumors. 4. Genome-based Cancer Care “Arms Race” on patient genome sequencing capabilities to more precisely prevent and treat cancer. 5. Genome (vs. Tumor Site) Driving Future of Cancer Treatment to better treat patients’ specific cancers.
  16. 16. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Patient-Centered Medical Homes • CMS awarded a $19 million grant to implement PCMH models in seven oncology practices across the U.S. Background • Many oncology centers are developing oncology- based medical homes in an effort to improve care and quality while decreasing high costs associated with oncology. Why PCMH? • Accessible, comprehensive and coordinated care through a systems-based approach. • Clinical staff better serve their patients by developing and maintaining an active partnership with them and providing proactive, preventative and chronic care management, which in turn, prevents complications and hospitalizations. Benefits
  17. 17. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Patient-Centered Medical Homes • Gaps between quality and care delivery standards in oncology could be addressed by PCMH model. • PCMH principals could encourage rational utilization of healthcare resources through the use of:  Evidence-based guidelines  Reduced hospitalizations, ED visits, and imaging  Increased engagement with patients, especially for end-of-life care decisions • The Results Don’t Lie!  Reduced hospitalizations, ER visits, imaging services, and diagnostics  Improved coordination of services, patient communication, and overall efficiency  The practice reduced its staff-to-physician ratio from 8.3 FTEs to 5.5 FTEs and increased its patient base by 30 percent
  18. 18. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Commonality Among Top Oncology Programs Oncology leaders at the nation’s top hospitals shared 11 trends in hospitals’ cancer care… Increasing outpatient care Focusing on patient-centered care Personalizing medicine through genetic analysis for effective treatment Increasing cost awareness Focusing on outcomes by adhering to evidence-based practices Coordinating care through technology Offering services which compliment patient’s treatment Coordinating cancer services to treat the whole patient Enhancing survivorship programs Offering palliative care services Offering more educational opportunities for patients
  19. 19. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Emerging Personalized, Molecular Treatments  Ability to target agents directed specifically to molecular abnormalities driving specific tumors Yesterday… Today…  Surgery  Chemotherapy  Radiation Rough Tools: Personalized Medicine:
  20. 20. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Genome-Based Cancer Care “Arms Race” • Cancer care providers, particularly academic medical centers, are launching an “arms race” on patient genome sequencing capabilities in order to more precisely prevent and treat cancer. – Johns Hopkins – “systematic genomic sequencing program” – Phoenix Children’s Hospital – Ronald A. Matricaria Institute of Molecular Medicine
  21. 21. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Genome Driving Future of Cancer Treatment
  22. 22. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Clinical Integration and Radiation Oncology General Considerations
  23. 23. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Consider: Transition to Coordinated Care • Consolidation of the Hospital Market – The number of hospitals that are part of a health system has been growing steadily for more than a decade. – Almost 60% of hospitals are now part of a system. – Health system executives are increasingly asking their oncology service line leaders to devise plans that promote coordination, collaboration, and more efficient use of resources.
  24. 24. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Consider: Transition to Coordinated Care • Many health systems were created through mergers and acquisitions. • Consequentially, cancer programs that were once competitors may find themselves part of the same institution, which is a challenging starting point for collaboration. • Even if the cancer programs are located in different markets, they will likely have different organizational models, physician governance
  25. 25. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Consider: Narrow Network Concerns for Cancer Centers Cancer patients relieved that they can get insurance coverage because of the new health law may be disappointed to learn that some of the nation’s best cancer hospitals are off limits.
  26. 26. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Consider: Narrow Network Concerns for Cancer Centers • The Associated Press surveyed 23 institutions around the country that are part of the National Comprehensive Cancer Network (NCCN). • Only four out of the 19 nationally recognized comprehensive cancer centers that responded to the survey said patients have access through all the insurance companies in their state exchange. • These patients may not be able to get the most advanced treatment, including clinical trials and medications.
  27. 27. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference The National Benchmark for Oncology, 2013 Report on 2012 Data
  28. 28. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Survey Responses Response to survey question “Do you expect to be impacted by an ACO [accountable care organization] in the coming year?” • Practices, 93 • Full-time equivalent physicians, 814
  29. 29. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Survey Responses Response to survey question “If yes, do you expect to participate in risk/reward with the ACO [accountable care organization]?” • Practices, 67 • Full-time equivalent physicians, 637
  30. 30. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Survey Responses Response to survey question “Do the physicians in your practice regularly use practice guidelines or clinical pathways for patient care?” • Practices, 86 • Full-time equivalent hematology/oncology physicians, 663 • FTE physicians, 812
  31. 31. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Survey Responses Source of clinical pathways • Practices, 46 • Full-time equivalent hematology/oncology physicians, 304 • FTE physicians, 391
  32. 32. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Survey Responses Response to survey question “How do you use clinical pathway data?” • Practices, 43 • Full-time equivalent hematology/oncology physicians, 291 • FTE physicians, 376
  33. 33. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Why Clinical Integration? • Today’s volume-based, fee-for-service system is based on independence: each provider is paid for providing a discrete service, without regard to others’ performance. • Tomorrow’s value-based payment systems, however, will demand interdependence: providers will be rewarded for quality and efficiency achieved through collaborative care
  34. 34. April 24-25, 2014 Prepared for SATRO ® 16th Annual Conference Christopher Wilson, J.D., M.P.H. Senior Manager cwilson@pyapc.com 913-232-5145

×